Quality, safety and legislation for herbal products (India, USA, EU) MCQs With Answer

Introduction

The following quiz is designed for M.Pharm students studying Regulatory Aspects of Herbal and Biologicals (MRA202T). It focuses on quality, safety and legislation governing herbal products in India, the USA and the EU. Questions cover key regulations, registration routes, quality specifications, pharmacopoeial standards, pharmacovigilance and manufacturing requirements. This set emphasises regulatory differences for dietary supplements, traditional herbal medicinal products and phytopharmaceuticals, and highlights testing parameters such as contaminants, stability and documentation needed for approvals. Use these MCQs to test understanding of statutory frameworks, practical compliance expectations and regulatory pathways relevant to herbal drug development and marketing in major jurisdictions.

Q1. Which primary Indian legislation governs manufacture and marketing of Ayurvedic, Siddha and Unani (ASU) drugs?

• Food Safety and Standards Act, 2006
• Drugs and Cosmetics Act, 1940
• Disease Control Act, 1986
• Pharmacy Act, 1948

Correct Answer: Drugs and Cosmetics Act, 1940

Q2. Which Indian ministry is the principal authority for traditional systems like Ayurveda, Yoga, Unani, Siddha and Homeopathy?

• Ministry of Health and Family Welfare (MoHFW)
• Ministry of Science and Technology
• Ministry of AYUSH
• Central Drugs Standard Control Organization (CDSCO)

Correct Answer: Ministry of AYUSH

Q3. Which EU legislative act introduced a simplified registration route for traditional herbal medicinal products?

• Directive 2001/83/EC (no amendments)
• Regulation (EC) No 726/2004
• Directive 2004/24/EC (Traditional Herbal Medicinal Products Directive)
• Directive 2010/84/EU

Correct Answer: Directive 2004/24/EC (Traditional Herbal Medicinal Products Directive)

Q4. In the United States, which law specifically defines and regulates dietary supplements?

• Federal Food, Drug, and Cosmetic Act (FD&C Act) without amendments
• Dietary Supplement Health and Education Act (DSHEA) 1994
• Biologics Control Act
• Herbal Medicinal Products Act

Correct Answer: Dietary Supplement Health and Education Act (DSHEA) 1994

Q5. Which CFR part contains current good manufacturing practices (cGMP) specific to dietary supplements in the USA?

• 21 CFR Part 210
• 21 CFR Part 211
• 21 CFR Part 111
• 21 CFR Part 820

Correct Answer: 21 CFR Part 111

Q6. Which EMA body is primarily responsible for scientific assessment and monographs for herbal medicinal products in the EU?

• Committee for Medicinal Products for Human Use (CHMP)
• Committee on Herbal Medicinal Products (HMPC)
• Pharmacovigilance Risk Assessment Committee (PRAC)
• European Centre for Disease Prevention and Control (ECDC)

Correct Answer: Committee on Herbal Medicinal Products (HMPC)

Q7. How is a “phytopharmaceutical” defined under Indian regulatory guidance for new drug approvals?

• An unstandardized crude herbal powder sold as a supplement
• A purified and standardized fraction of a medicinal plant extract with defined chemical markers and evidence of safety and efficacy
• Any herbal formulation registered under FSSAI as food
• A homeopathic dilution of a botanical material

Correct Answer: A purified and standardized fraction of a medicinal plant extract with defined chemical markers and evidence of safety and efficacy

Q8. Which official publication serves as a national reference for standards of Ayurvedic medicines in India?

• United States Pharmacopeia (USP)
• European Pharmacopoeia
• Ayurvedic Pharmacopoeia of India
• British Pharmacopoeia

Correct Answer: Ayurvedic Pharmacopoeia of India

Q9. Which FDA guidance specifically addresses development of botanical drugs in the USA?

• Guidance for Industry: Botanical Drug Development (2004)
• Guidance for Industry: Dietary Supplement Labeling (2011)
• Guidance for Industry: Biologics License Application (2012)
• Guidance for Industry: Generic Drug Development (2013)

Correct Answer: Guidance for Industry: Botanical Drug Development (2004)

Q10. Under US regulations for dietary supplements, manufacturers are required to report serious adverse events to FDA within what timeframe?

• Within 24 hours
• Within 7 days
• Within 15 business days
• No reporting requirement exists

Correct Answer: Within 15 business days

Q11. For traditional-use registration under the EU THMPD, a medicinal product must generally demonstrate how many years of traditional use?

• 5 years globally
• 10 years, 5 within the EU
• 30 years of traditional use, including at least 15 years within the EU
• No evidence of traditional use is required

Correct Answer: 30 years of traditional use, including at least 15 years within the EU

Q12. What type of information do HMPC monographs typically provide for herbal substances?

• Only botanical illustrations
• Manufacturing pricing details for industry
• Scientific assessment including quality, safety and efficacy data to support regulatory decisions
• Marketing strategies for herbal products

Correct Answer: Scientific assessment including quality, safety and efficacy data to support regulatory decisions

Q13. Which quality specifications are routinely required for herbal raw materials and finished products to ensure safety?

• Only organoleptic evaluation
• Contaminant limits such as heavy metals, pesticide residues, microbial limits and aflatoxins
• Only moisture content and particle size
• Only extractive value

Correct Answer: Contaminant limits such as heavy metals, pesticide residues, microbial limits and aflatoxins

Q14. In India, which schedule of the Drugs and Cosmetics Rules prescribes Good Manufacturing Practices (GMP) for ASU drug manufacturing?

• Schedule M
• Schedule T
• Schedule Y
• Schedule V

Correct Answer: Schedule T

Q15. To market a botanical product as a drug in the USA rather than a dietary supplement, a sponsor generally must obtain what approval?

• GRAS notification
• New Drug Application (NDA) approval demonstrating safety and efficacy
• FSSAI license
• THMPD certificate from EMA

Correct Answer: New Drug Application (NDA) approval demonstrating safety and efficacy

Q16. Which pharmacopoeial compendium is commonly used by EU regulators as an authoritative reference for herbal monographs and quality standards?

• United States Pharmacopeia (USP)
• European Pharmacopoeia
• British Herbal Compendium (non-official)
• Ayurvedic Pharmacopoeia of India

Correct Answer: European Pharmacopoeia

Q17. Under DSHEA, which type of claim is specifically prohibited for dietary supplements in the USA?

• Structure/function claims with proper disclaimer
• Claims to diagnose, treat, cure, or prevent any disease
• Claims about nutrient content per serving
• Claims regarding traditional use in food

Correct Answer: Claims to diagnose, treat, cure, or prevent any disease

Q18. Which stability guideline is commonly adapted for stability testing of herbal medicinal products intended for the EU market?

• ICH Q1A guideline adapted for botanicals
• ISO 9001 only
• EPA environmental stability guideline
• No stability testing is required for herbal products

Correct Answer: ICH Q1A guideline adapted for botanicals

Q19. Which electronic system is used in the EU to collect and manage suspected adverse reactions to medicines, including herbal medicinal products?

• FAERS (FDA Adverse Event Reporting System)
• VigiBase (WHO)
• EudraVigilance
• MedWatch

Correct Answer: EudraVigilance

Q20. Which Indian regulatory authority is primarily responsible for regulating food supplements that contain herbal ingredients?

• Central Drugs Standard Control Organization (CDSCO)
• Ministry of AYUSH
• Food Safety and Standards Authority of India (FSSAI)
• Indian Council of Medical Research (ICMR)

Correct Answer: Food Safety and Standards Authority of India (FSSAI)

Download